AQYLA BioVentures

📍 Wavre, Belgium🗓 Founded 2024👥 4 employees💰 Last funded Dec 2024
Biotechnology Research
LinkedIn
AQYLA BioVentures is a TechBio venture studio that discovers its own drug targets and builds biotech companies around them. We validate biology before deploying capital — using human disease models, causal BioML, and ChemAI — then launch SpinCos we fully own until Series A. Our first SpinCo, hit its first milestone in six months. Were scaling to five SpinCos by 2030. Website under construction, coming soon !
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2024
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
France
1
Frequently asked questions
Who invested in AQYLA BioVentures?
AQYLA BioVentures has 1 investors on record on gritt.io, including 1 early-stage backers.
When did AQYLA BioVentures last raise funding?
The most recent investment in AQYLA BioVentures recorded on gritt.io was in December 2024.
When was AQYLA BioVentures founded?
AQYLA BioVentures was founded in 2024.
What industry is AQYLA BioVentures in?
AQYLA BioVentures operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is AQYLA BioVentures based?
AQYLA BioVentures is headquartered in Wavre, Belgium.